The stock of Redx Pharma PLC (LON:REDX) is a huge mover today! The stock decreased 1.49% or GBX 0.65 on November 8, hitting GBX 42.85. About 72,619 shares traded hands. Redx Pharma PLC (LON:REDX) has risen 6.10% since April 7, 2016 and is uptrending. It has outperformed by 4.14% the S&P500.
The move comes after 8 months negative chart setup for the GBX 39.73 million company. It was reported on Nov, 8 by Barchart.com. We have GBX 37.71 PT which if reached, will make LON:REDX worth GBX 4.77 million less.
Redx Pharma Plc, formerly Redx Pharma Ltd, is engaged in drug discovery, pre-clinical development and licensing. The company has a market cap of 39.73 million GBP. The Firm is engaged in drug discovery across cancer, infection and autoimmune diseases. It currently has negative earnings. The Firm has over two programs in its oncology research activity, Smoothened Hedgehog and Bruton’s Tyrosine Kinase (BTK), which has reached candidate nomination stage.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.